These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. Lu X; Farmer P; Rubin J; Nanes MS J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3). Chen ML; Ray S; Swamy N; Holick MF; Ray R Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974 [TBL] [Abstract][Full Text] [Related]
7. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738 [TBL] [Abstract][Full Text] [Related]
8. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element. Uchida M; Ozono K; Pike JW J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065 [TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
11. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements. Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764 [TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465 [TBL] [Abstract][Full Text] [Related]
13. Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. Dong X; Craig T; Xing N; Bachman LA; Paya CV; Weih F; McKean DJ; Kumar R; Griffin MD J Biol Chem; 2003 Dec; 278(49):49378-85. PubMed ID: 14507914 [TBL] [Abstract][Full Text] [Related]
14. The impact of chromatin organization of vitamin D target genes. Carlberg C; Dunlop TW Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674 [TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. Wietzke JA; Ward EC; Schneider J; Welsh J Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452 [TBL] [Abstract][Full Text] [Related]
18. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. Harant H; Spinner D; Reddy GS; Lindley IJ J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570 [TBL] [Abstract][Full Text] [Related]
19. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Peng L; Malloy PJ; Feldman D Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110 [TBL] [Abstract][Full Text] [Related]
20. Oestradiol decreases rat apolipoprotein AI transcription via promoter site B. Taylor AH; Fox-Robichaud AE; Egan C; Dionne J; Lawless DE; Raymond J; Romney J; Wong NC J Mol Endocrinol; 2000 Oct; 25(2):207-19. PubMed ID: 11013347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]